Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZYME · against 1,335 other Healthcare companies
Ranked #1,250 of 1,336 · scores higher than 6% of peers
Bars: peers in each 10-point band of the profitability score127 peers with a profitability score of 0–9, including ZYME · Click a bar to see the companies
Mainly because of its operating margin and return on assets, which are weaker than most Healthcare peers.
| Metric | ZYME | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | Not reported | 4.7% | — | — | 33% |
| Operating marginHigher is better · 1,251 reported | -419.0% | 7.1% | 7% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -37.8% | 1.7% | 11% | 33% | |
| Return on equityHigher is better · 1,252 reported | -72.3% | 3.2% | 10% | Context only | |
| Gross marginHigher is better · 1,394 reported | -246.7% | 45.9% | 0% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 1,250 | 540M ILS (≈$146M) | 6 | 49 | |
| 1,250 | 26.0B USD | 6 | 28 | |
| 1,250 | 354M USD | 6 | 13 | |
| 1,250 | 314M USD | 6 | 56 | |
| 1,250 | 2.2B USD | 6 | 20 | |
| 1,263 | 10.8B JPY (≈$73M) | 5 | 27 | |
| 1,263 | 397M USD | 5 | 37 | |
| 1,263 | 389M USD | 5 | 33 | |
| 1,263 | 274M USD | 5 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score